Clinical Trials

1,061 enrolled

Classical hematology

Anemia, Sickle Cell, Cardiovascular Diseases, Diabetes Mellitus, Neoplasms, Sickle Cell Trait

NCT02911064 2026-04-16

Expectations Regarding Mobility and Self-Care

133 enrolled

Phase 1/2 Active not recruiting

Neoplasms

NCT03157128 2026-04-16

LIBRETTO-001

857 enrolled 24 charts 6 FDA

BreastCNSEndocrineGastrointestinalHead & NeckThoracic

Thyroid Cancer, Papillary, Breast Neoplasms, Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Endocrine System Diseases, Endocrine Gland Neoplasms, Head and Neck Neoplasms, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms, Thyroid Diseases, Thyroid Neoplasms, Central Nervous System Neoplasms, Carcinoma, Medullary

NCT03328078 2026-04-16

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Phase 1/2 Recruiting

152 enrolled

LymphoidOther hematologic neoplasm

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Recurrence, Hematologic Neoplasms

NCT04421963 2026-04-16

ROSY-O

Phase 3 Active not recruiting

185 enrolled

BreastGynecologic

Breast Neoplasms, Neoplasms, Ovarian Neoplasms

NCT05064280 2026-04-16

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

104 enrolled

Phase NA Active not recruiting

Brain Neoplasms, Neoplasms

NCT05256225 2026-04-16

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

Phase 3 Recruiting

360 enrolled

Gynecologic

Neoplasms, Endometrial Neoplasms

NCT05436327 2026-04-16

Improving Communication for Cancer Treatment: Addressing Concerns of Older Cancer Patients and Caregivers

479 enrolled

Communication, Neoplasms

NCT05470283 2026-04-16

Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma

Phase 1 Active not recruiting

21 enrolled

Dermatologic

Melanoma, Neoplasms

NCT05493020 2026-04-16

The Association Between Watching Mukbang Videos and the Appetite of Children With Cancer

179 enrolled

Neoplasms, Malnutrition

NCT05588141 2026-04-16

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

Phase 1/2 Recruiting

96 enrolled

Brain Neoplasms, Glioma, Neoplasms, Recurrence

NCT05836857 2026-04-16

The Use of Cannabis (Marijuana) and Cannabidiol (CBD) Among Cancer Patients: A Pilot Study

100 enrolled

Neoplasms

NCT06329531 2026-04-16

Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic

Neoplasms

NCT06510699 2026-04-16

PRAGMATIC

Other hematologic neoplasm

104 enrolled

Communicable Diseases, Infections, Mycoses, Neoplasms, Hematologic Neoplasms

NCT06744283 2026-04-16

Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia

20 enrolled

Classical hematology

Fanconi Anemia, Neoplasms

NCT06801041 2026-04-16

TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors

20 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT06959706 2026-04-16

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

Phase 1 Recruiting

50 enrolled

Classical hematologyDermatologicSarcoma

Carcinoma, Neoplasms

NCT07005297 2026-04-16

Clinical Genetics Branch Eligibility Screening Survey

Not yet recruiting

1,000 enrolled

Cardiofaciocutaneous syndrome, Legius syndrome, Congenital Bone Marrow Failure Syndromes, Melanoma, Cutaneous Malignant, Chordoma, Fanconi Anemia, Melanoma, Neoplasms, Li-Fraumeni Syndrome, Pulmonary Blastoma, Costello Syndrome

NCT07075185 2026-04-16

inMMyCAR

Phase 1 Recruiting

40 enrolled

LymphoidPlasma cell

Blood Protein Disorders, Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Hemostatic Disorders

NCT07100730 2026-04-16

IPAX BrIGHT

Phase 3 Recruiting

50 enrolled

Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Neoplasms, Central Nervous System Neoplasms

NCT07326800 2026-04-16

MAEva-MCT

190 enrolled

Phase 1/2 Not yet recruiting

Neoplasms

NCT07416188 2026-04-16

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

40 enrolled

Phase NA Not yet recruiting

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Nerve Tissue, Recurrence, Central Nervous System Neoplasms

NCT07499128 2026-04-16

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

136 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Cytokine Release Syndrome, Lymphoma, Multiple Myeloma, Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07504458 2026-04-16

QUATRO-APL

Phase 3 Recruiting

150 enrolled

Other hematologic neoplasm

Hematologic Diseases, Leukemia, Neoplasms, Leukemia, Promyelocytic, Acute, Hematologic Neoplasms

NCT07532057 2026-04-16

PR-LUNGCA-2019

Phase NA Completed

30 enrolled

Thoracic

Lung Neoplasms, Neoplasms, Small Cell Lung Carcinoma

NCT07532668 2026-04-16

SARCOPALL

Phase 2 Not yet recruiting

207 enrolled

Sarcoma

Death, Neoplasms, Sarcoma

NCT07533227 2026-04-16

FMT-CACH

66 enrolled

Cachexia, Neoplasms

NCT01481532 2026-04-15

Open Label Clinical Trial of Intravenous Crotoxin Part 3

Phase 1 Not yet recruiting

24 enrolled

Neoplasms

NCT02337452 2026-04-15

Web-Based Family Outreach Program for Cancer Prevention in High-Risk Families

10 enrolled

BreastGastrointestinalGenitourinaryGynecologicLymphoid

Neoplasms

NCT02379520 2026-04-15

HESTIA

Phase 1 Completed

32 enrolled

Neoplasms, Recurrence

NCT03935282 2026-04-15

AH-HA

Phase NA Completed

645 enrolled 43 charts

Breast Neoplasms, Cardiovascular Diseases, Hodgkin Disease, Lymphoma, Non-Hodgkin, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Health Behavior, Endometrial Neoplasms

NCT03952624 2026-04-15

Patient-Centered Assessment of Symptoms and Outcomes

692 enrolled

Fatigue, Neoplasms, Fatigue Syndrome, Chronic

NCT04053517 2026-04-15

Financial Distress in Advanced Cancer Patients

141 enrolled

Neoplasm Metastasis, Neoplasms, Recurrence

NCT04452825 2026-04-15

A New Psychotherapy Intervention for Older Cancer Patients

459 enrolled

Phase 3 Active not recruiting

Neoplasms

NCT04464226 2026-04-15

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

402 enrolled

Neoplasms

NCT04486378 2026-04-15

A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer

Phase NA Active not recruiting

327 enrolled

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT04905069 2026-04-15

SABRE

500 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT05065801 2026-04-15

GABRINOX2

162 enrolled

Gastrointestinal

Neoplasms, Pancreatic Neoplasms

NCT05164016 2026-04-15

Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients

Other hematologic neoplasm

21 enrolled

Neoplasms, Hematologic Neoplasms

NCT05376891 2026-04-15

Met Non Small Cell Cancer Registry (MOMENT)

700 enrolled

Neoplasms

NCT06458036 2026-04-15

RAISE

Phase 2 Active not recruiting

13 enrolled

Head & Neck

Neoplasms, Thyroid Neoplasms

NCT06502977 2026-04-15

DeLLphi-307

32 enrolled 9 charts

EndocrineNET

Neoplasms, Neuroendocrine Tumors

NCT06634589 2026-04-15

A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Phase 1/2 Recruiting

Lymphoid

Neoplasms, Recurrence, Lymphoma, B-Cell

NCT06892158 2026-04-15

Massage Impact on Sleep in Pediatric Oncology

LymphoidOther hematologic neoplasm

70 enrolled

Neoplasms, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07005102 2026-04-15

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Phase 2/3 Recruiting

854 enrolled

Neoplasms

NCT07094204 2026-04-15

A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors

Phase 1 Recruiting

364 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

NCT07216443 2026-04-15

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

MyeloidOther hematologic neoplasmOther neoplasm

Acute Disease, Bone Marrow Diseases, Disease, Graft vs Host Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Precancerous Conditions, Preleukemia, Syndrome, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Disease Attributes

NCT07305740 2026-04-15

On-Trac

Anxiety Disorders, Neoplasms

NCT07342335 2026-04-15

Breaking Barriers to Research Access

300 enrolled